These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6625461)

  • 1. [Accidental leukomelanoderma induced by topical depigmenting agents].
    Frenk E
    Ann Dermatol Venereol; 1983; 110(4):381-2. PubMed ID: 6625461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acquired leukomelanoderma caused by topical depigmenting agents].
    Grojean MF; Thivolet J; Perrot H
    Ann Dermatol Venereol; 1982; 109(8):641-7. PubMed ID: 7187189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Melanoleukoderma following treatment with hydroquinone monobenzylether].
    Balabanow K; Durmischev AL; Tschernozemsky I
    Asthet Med (Berl); 1968 Oct; 17(10):233-4. PubMed ID: 5306153
    [No Abstract]   [Full Text] [Related]  

  • 4. Current contact news. Hydroquinone uses and abnormal reactions.
    Fisher AA
    Cutis; 1983 Mar; 31(3):240-4, 250. PubMed ID: 6220868
    [No Abstract]   [Full Text] [Related]  

  • 5. Monobenzone, Superfade, vitiligo and confetti-like depigmentation.
    Catona A; Lanzer D
    Med J Aust; 1987 Mar; 146(6):320-1. PubMed ID: 3821640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Accidental leukoderma].
    Zar E
    G Ital Dermatol Minerva Dermatol; 1970 Oct; 45(10):594-5. PubMed ID: 5536168
    [No Abstract]   [Full Text] [Related]  

  • 7. Probable allergic contact dermatitis from hydroquinone presenting as leukomelanoderma: Report of two cases.
    Yanagishita-Nakatsuji S; Fukai K; Ohyama A; Umekoji A; Sowa-Osako J; Tsuruta D
    J Dermatol; 2017 Dec; 44(12):e330-e331. PubMed ID: 28815722
    [No Abstract]   [Full Text] [Related]  

  • 8. Leucomelanoderma in blacks. A recent epidemic.
    Dogliotti M; Caro I; Hartdegen RG; Whiting DA
    S Afr Med J; 1974 Aug; 48(37):1555-8. PubMed ID: 4852984
    [No Abstract]   [Full Text] [Related]  

  • 9. [Depigmentation effect of hydroquinone monomethyl ether].
    Durmischev AL; Davidoff MS
    Dermatol Monatsschr; 1976 Apr; 162(4):306-11. PubMed ID: 955213
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Fade out' photochromonychia.
    Coulson IH
    Clin Exp Dermatol; 1993 Jan; 18(1):87-8. PubMed ID: 8440066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Depigmentation for cosmetic purposes: prevalence and side-effects in a female population in Senegal].
    Raynaud E; Cellier C; Perret JL
    Ann Dermatol Venereol; 2001; 128(6-7):720-4. PubMed ID: 11460033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukomelanodermia areata (dyschromia "en confetti") caused by the application of monobenzylether of hydroquinone (author's transl)].
    Kastl J; Horácek J
    Cesk Dermatol; 1981 Oct; 56(5):312-7. PubMed ID: 7307092
    [No Abstract]   [Full Text] [Related]  

  • 13. [Confetti-like dyschromia caused by a bleaching cream containing hydroquinone in racially pigmented patients].
    Haas N
    Med Klin (Munich); 1988 May; 83(11):385-6, 390. PubMed ID: 3405155
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental skin depigmentation. II. Epidermal reaction in external administration of depigmenting substances].
    Wohlrab W; Zaumseil RP
    Dermatol Monatsschr; 1976 Dec; 162(12):980-5. PubMed ID: 1021476
    [No Abstract]   [Full Text] [Related]  

  • 15. [Letter: Lasting depigmentation caused by hydroquinonemonobenzylether].
    Fitzpatrick B
    Hautarzt; 1975 Jan; 26(1):56. PubMed ID: 1116947
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution to the knowledge of dyschromia "en confetti". Clinical and histochemical note].
    Levi L; Vivarelli I
    G Ital Dermatol Minerva Dermatol; 1967; 108(4):267-78. PubMed ID: 5633131
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leucodermia acquisita areata caused by monobenzylether of hydroquinone (author's transl)].
    Hegyi E; Valková P; Mat'oska J
    Cesk Dermatol; 1979 Feb; 54(1):6-8. PubMed ID: 761240
    [No Abstract]   [Full Text] [Related]  

  • 18. [Irreversible toxic depigmentation. Observations following use of hydroquinonemonobenzylether-containing skin bleaching preparations].
    Heilgemeir GP; Balda BR
    MMW Munch Med Wochenschr; 1981 Jan; 123(2):47-8. PubMed ID: 6782448
    [No Abstract]   [Full Text] [Related]  

  • 19. Occupational depigmentation due to a hydroquinone-containing photographic developer.
    Frenk E; Loi-Zedda P
    Contact Dermatitis; 1980 Apr; 6(3):238-9. PubMed ID: 6446441
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of over-the-counter hydroquinone bleaching creams.
    Brauer EW
    Arch Dermatol; 1985 Oct; 121(10):1239. PubMed ID: 4037812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.